首页> 外文期刊>Leukemia and lymphoma >Mantle cell lymphoma in a mother and her daughter.
【24h】

Mantle cell lymphoma in a mother and her daughter.

机译:一位母亲和她的女儿的套细胞淋巴瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

Mantle cell lymphoma (MCL) was reported to be another potential familial lymphoproliferative disease for the first time in 2004 [1]. Since then, no similar cases have been reported. Here we describe a familial MCL first occurring in the pattern of mother and daughter. A 45-year-old female presented with colonic polyposis and was initially diagnosed with inflammatory bowel disease. After 2 months of mesalazine therapy, the related symptoms were not reduced. Subsequently, a right elbow lymph node biopsy showed lymphadenosis positive for MUM-1, Bcl-2, CD79a, p53, Bcl-6, and cyclin D1, and negative for CD3, CD5, CD10, and CD30. Further abdominal computed tomography (CT) evaluation revealed the walls of the stomach, duodenum, distal ileum, and rectum to be significantly thickened. She was diagnosed as having MCL (stage IV), and achieved a partial response after two cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincris-tine, prednisone).
机译:据报道,2004年套细胞淋巴瘤(MCL)是另一种潜在的家族性淋巴增生性疾病[1]。从那以后,没有类似的案例被报道。在这里,我们描述了家族性的MCL,它首先以母女的形式出现。一名45岁女性出现结肠息肉病,最初被诊断为炎症性肠病。美沙拉嗪治疗2个月后,相关症状未减轻。随后,右肘淋巴结活检显示MUM-1,Bcl-2,CD79a,p53,Bcl-6和cyclin D1呈淋巴结阳性,而CD3,CD5,CD10和CD30呈阴性。进一步的腹部计算机断层扫描(CT)评估显示,胃,十二指肠,回肠远端和直肠壁显着增厚。她被诊断患有MCL(IV期),并且在两个周期的R-CHOP(利妥昔单抗,环磷酰胺,阿霉素,长春新碱,泼尼松)后获得部分缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号